MS Patients Being Evaluated as Fit to Work, Receiving Lower Benefits, Charities Alert
Patients who suffer from progressive conditions, such as multiple sclerosis (MS), are submitted to unnecessary evaluations for disability benefits…
Articles by Patricia Silva, PhD
Biogen Idec Gives $1.4M to New MS Research Program in Alberta
Photo From University of Alberta The company behind FDA-approved multiple sclerosis drug…
Teva and Active Biotech Expand Investigational MS Treatment Program
Drug manufacturers Teva Pharmaceutical Industries Ltd. and Active Biotech announced that they expanding the ongoing clinical research program…
Genzyme Clinical Trial for Relapsing-Remitting MS Enrolls 1st Patient
Sanofi subsidiary and rare disease treatment specialist Genzyme has just announced the successful enrollment of the first participant in their multicenter…
National MS Society Grants $457,921 to Kessler Foundation Researcher
The National Multiple Sclerosis Society recently awarded MS researcher Lauren Strober, PhD from the Kessler Foundation,…
Sydney Bikers Join Efforts to Fundraising on MS Gong Ride Sunday
Next Sunday, November 2nd, Sydney, Australia will hold one of the country’s largest fundraising events to support multiple sclerosis research…
Philip De Jager Awarded 2014 Barancik Prize for Innovation in MS Research
The National Multiple Sclerosis Society granted the 2014Â Barancik Prize for Innovation in MS Research to Philip…
Positive Data from Two Key MS Trials Added To Aubagio’s U.S. Label
The Food and Drug Administration (FDA) recently accepted the results from Genzyme’s TOWER and TOPIC  clinical trials, which assessed the…
MS Society Canada Urges Parliamentarians to Improve MS Clinics
While Canada is home to one of the world’s most comprehensive social healthcare systems, it is unfortunately home to…
Opexa Joins National Multiple Sclerosis Society to Sponsor Walk MS
The National Multiple Sclerosis Society‘s Lone Star Chapter, which is sponsoring the nonprofit organization’s annual Houston-area Walk MS fundraisers, has…
Consortium of MS Centers Hosts Annual Meeting Next May in Indiana
The Consortium of Multiple Sclerosis Centers (CMSC) has announced that its next annual meeting will be held in 2015…
Dimension Data Helps Raise $130K for National MS Society
One of the most effective and engaging fundraising strategies the National Multiple Sclerosis Society organizes annually is the…
David Osmond Sings for Novartis MS Awareness Campaign
A member of the musical Osmond family, David Osmond, recently released a music video for his inspirational song “I Can…
MS Blueprint Online Program by Biogen Helps Patients Live Happier
Cambridge, Massachusetts-based Biogen Idec has just announced a new support program for people living with multiple sclerosis (MS) that encourages patients…
5-Course Dinner Raises $445K for Multiple Sclerosis Society of Canada
Heartwarming support for multiple sclerosis campaigns and charity events poured in at last week’s exclusive gastronomic fundraising event, the Toqué! for…
Free Continuing Education for MS Care Providers Starts in November
Several national health organizations have come together to design a series of continuing education opportunities focused on better managing multiple…
U.S. Supreme Court Gives Teva Mixed Reception on Copaxone Patent Case
The U.S. Supreme Court deliberated on a request from Teva Pharmaceutical Industries Ltd. to preserve the patent…
Revenge Star Madeleine Stowe is the New Face of Multiple Sclerosis
Featureflash / Shutterstock.com Television’s “Queen of Mean,” Revenge‘s Madeleine Stowe, recently opened up about her early memories of…
Urinary Prosthesis Better than Catheterization for Female MS Patients
One of the concerns patients with neurologic diseases such as multiple sclerosis face is decline or loss of bladder control. It…
New Multiple Sclerosis Research Will Focus On Cytokine Regulation, Neuroprotection, Tolerance Induction
Evotec AG, a German company specializing in the provision of drug discovery resources to biotech companies and learning…
Ankar Pharma Opens Crowdfunding for Promising MS Drug
Spanish-Filipino biopharmaceutical startup Ankar Pharma is working on a promising treatment for multiple sclerosis (MS). Dr. Ana Martinez, a professor and…
PHARMAC Approves Funding New RRMS Treatments in New Zealand
New Zealand-based Pharmaceutical Management Agency (PHARMAC) has approved the funding of new treatments for multiple sclerosis (MS), which…
Alabama Representative Honored at National MS Society Ball
The National Multiple Sclerosis Society recently honored several admirable MS advocates and leaders during the annual NMSS Ambassadors Ball, held…
MS Association in Germany Invites Thomas Erning to Present Novel
Germany’s Multiple Sclerosis Association is hosting an event dedicated to recognizing those who have devoted much of their time…
New Long-lasting Multiple Sclerosis Drug Will Come At a Steep Price
Now more than ever, groundbreaking, new therapies for chronic diseases and infections come with high price tags. Earlier in…
NICE Releases New Guidance on Multiple Sclerosis Care
The British National Institute for Health and Care Excellence (NICE) updated their guidelines on the provision of…
Oklahoma Medical Research Foundation Receives Multiple Sclerosis Innovation Grant
A scientist from the Oklahoma Medical Research Foundation (OMRF) is the recipient of 1 of only 5 Multiple Sclerosis Innovation…
National MS Society Pledges $19 Million Dollars to Fund 54 New Studies
54 new multiple sclerosis (MS)Â research and development initiatives are set to receive substantial funding in order to…
Glialogix Drug for Progressive MS Funded by National Multiple Sclerosis Society
San Francisco Bay Area-based Glialogix, Inc., a biopharmaceutical company that specializes in developing novel treatments for multiple…
Multiple Sclerosis Self-Management Scale Enhances Patient Independence
Multiple sclerosis (MS) is a chronic, autoimmune neurodegenerative disease that the biomedical research and pharmaceutical industry has…